Stroke, Acute Ischemic: Clinical Trials

14 trials for Stroke, Acute Ischemic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 4 recruiting, 3 not yet recruiting, 3 unknown. 14 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 314Completed 4, Recruiting 4, Not yet recruiting 3, Unknown 3
Phase 22Completed 1, Not yet recruiting 1

Follow Stroke, Acute Ischemic: new trials by email Literature Review of Stroke, Acute Ischemic trials Research Report on Stroke, Acute Ischemic

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
INTRA-ARTERIAL MeVO TREATMENT (IMP-ACT) Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
Mechanical Endovascular Thrombectomy, Intravenous Thrombolysis, Tenecteplase/Alteplase- depending upon availability at each treating centre - Stroke, Acute Ischemic, Medium Vessel Occlusion
Phase 3Not yet recruitingUniversity of Calgary8002026-12-152026-10-30
ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
Tenecteplase or Alteplase- depending upon availability at each treating centre, Control - Stroke, Acute Ischemic, Endovascular Thrombectomy
Phase 3RecruitingUniversity of Calgary15002026-08-112026-10-21
INtra-arterial AltEplase folloWing successfuL reperfusIoN After mEchanical Thrombectomy
Alteplase, Endovascular thrombectomy - Stroke, Acute Ischemic, Large Vessel Occlusion
Phase 3Recruiting115 People's Hospital4162026-08-012026-11-09
Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT)
Isosorbide Mononitrate, Butylphthalide, Isosorbide Mononitrate Placebo - Stroke, Lacunar, Stroke, Acute Ischemic
Phase 3Not yet recruitingBeijing Tiantan Hospital31562025-12-012025-11-26
Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window
Intravenous rhTNK-tPA, Intravenous placebo, Endovascular thrombectomy - Stroke, Acute Ischemic
Phase 3RecruitingXinqiao Hospital of Chongqing8202025-10-212025-12-31
Intra-Arterial Thrombolysis After SUCCESSful Reperfusion in Anterior Circulation Ischemic Stroke
Intra-arterial infusion of Alteplase - Stroke, Acute Ischemic
Phase 3RecruitingCentral Hospital, Nancy, France6262025-06-012025-06-05
Tirofiban for Successful Endovascular Stroke Thrombectomy
Intraarterial and intravenous tirofiban, Intraarterial and intravenous placebo - Stroke, Acute Ischemic
Phase 2 / Phase 3Not yet recruitingZhongming Qiu7122024-07-312024-05-16
Cerebroprotective Effect of Melatonin in Stroke
Melatonin 10 MG, Placebo - Stroke, Acute Ischemic, Strokes Thrombotic
Phase 3UnknownCoordinación de Investigación en Salud, Mexico1002024-03-012024-03-05
Intravenous Tirofiban Versus Thrombolysis Before Mechanical Thrombectomy in Stroke
Tirofiban, Thrombolysis - Stroke, Acute Ischemic
Phase 2 / Phase 3CompletedXinqiao Hospital of Chongqing10142023-11-282026-09-14
CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2).
Intraarterial alteplase - Stroke, Acute Ischemic, Stroke, Acute
Phase 3CompletedHospital Clinic of Barcelona4402023-11-182026-09-18
Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy
Alteplase - Stroke, Acute Ischemic
Phase 3CompletedSun Yat-Sen Memorial Hospital of Sun Yat-Sen University3242023-08-012026-08-12
Endovascular Thrombectomy With and Without Intravenous Thrombolysis in Extended Time Window
Intravenous thrombolysis agents, endovascular thrombectomy - Stroke, Acute Ischemic
Phase 3UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine2222022-12-032023-02-14
EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs
Tissue Plasminogen Activator (Alteplase) - Stroke, Acute Ischemic
Phase 3CompletedSecond Affiliated Hospital, Zhejiang University, School of Medicine2342022-08-172024-12-18
Mechanical Thrombectomy of Medium Sized Vessels "M2 of MCA".
Mechanical thrombectomy, medical treatment - Stroke, Acute Ischemic
Phase 3UnknownAssiut University602021-12-012021-10-25

Narrower conditions

Ischemic Stroke (14)  ·  Stroke (2)  ·  Cerebral Small Vessel Diseases (1)  ·  Stroke, Lacunar (1)  ·  Thrombotic Stroke (1)

Broader conditions

Brain Diseases (14)  ·  Cardiovascular Diseases (14)  ·  Central Nervous System Diseases (14)  ·  Cerebrovascular Disorders (14)  ·  Nervous System Diseases (14)  ·  Vascular Diseases (14)  ·  Stroke (12)  ·  Brain Infarction (1)  ·  Infarction (1)  ·  Ischemia (1)  ·  Necrosis (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Thrombotic Stroke (1)

Interventions

Tissue Plasminogen Activator (5)  ·  Fibrinolytic Agents (3)  ·  Tenecteplase (2)  ·  Tirofiban (2)  ·  3-n-butylphthalide (1)  ·  Infusions, Intra-Arterial (1)  ·  Melatonin (1)  ·  isosorbide-5-mononitrate (1)

Sponsors

Second Affiliated Hospital, Zhejiang University, School of Medicine (2)  ·  University of Calgary (2)  ·  Xinqiao Hospital of Chongqing (2)  ·  115 People's Hospital (1)  ·  Assiut University (1)  ·  Beijing Tiantan Hospital (1)  ·  Central Hospital, Nancy, France (1)  ·  Coordinación de Investigación en Salud, Mexico (1)  ·  Hospital Clinic of Barcelona (1)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)  ·  Zhongming Qiu (1)

Countries

China (5)  ·  Canada (2)  ·  Australia (1)  ·  France (1)  ·  Mexico (1)  ·  Spain (1)  ·  Vietnam (1)

Top investigators

Bijoy K Menon, MD (2)  ·  Craig Anderson, MD (2)  ·  Ana Morales, MD (1)  ·  Angel Chamorro, MD, PhD (1)  ·  Congguo Yin, Doctor (1)  ·  Daojun Hong, MD (1)  ·  Juan F Arenillas, MD (1)  ·  Laura Dorado, MD (1)  ·  Lluis Morales, MD (1)  ·  Maria Herrera, MD (1)

Results publications

PMID 39500603, PMID 33464335, PMID 35143603, PMID 35943471, PMID 39357896, PMID 40174223, PMID 41339082, PMID 41778584, PMID 42096239, PMID 42262770, PMID 42265863, PMID 42439416

NIH funding

2023 (2)